Press Releases

  • Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes With TrackWise

    Holmdel, NJ - June 30, 2008 - Sparta Systems, Inc. (Sparta), the maker of TrackWise® and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its quality management program.

    Genzyme purchased TrackWise to handle Corrective and Preventive Actions (CAPA) as well as deviations and investigations. The TrackWise solution was chosen to replace an existing solution and legacy systems due to its ease of use, extensive reporting capabilities, user interface and industry standard acceptance.

    According to Dave Dentino, director, quality and technical operations systems at Genzyme Corporation, “TrackWise has already proven itself through user acceptance and ease of configuration. We have already realized a benefit through the ease with which the system enabled global harmonization of our business processes.”

    “We are pleased that Genzyme selected Sparta to provide a single, consolidated tool for managing the core elements of their quality management operation,” said James E. McGowan, president and CEO, Sparta Systems. “TrackWise has become the industry standard due to its flexibility through configuration, ease of integration and unmatched functionality and we look forward to a future global deployment with Genzyme to all their manufacturing sites.”

    About Genzyme
     

    One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.


    About Sparta Systems

    Founded in 1994, Sparta Systems is the world’s premier provider of cloud and on-premise quality management software. We offer the solutions, analytics, and expertise that speed up quality and compliance. Our solutions help to lower risk, increase efficiency, and keep consumers safe while allowing manufacturers, suppliers, and distributors to collaborate in a seamless and integrated environment. Sparta is privately owned and headquartered in Hamilton N.J, with offices across Europe and Asia. We support close to 1 million users across 700+ implementations, in more than 30 countries. Companies in life sciences, consumer products, discrete manufacturing and more, rely on Sparta.

 
© 1995-2017 Sparta Systems, Inc. All Rights Reserved.
© 1995-2017 Sparta Systems, Inc. All Rights Reserved.Sparta Systems Logo